Chevy Chase Trust’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.9M Sell
113,295
-2,846
-2% -$591K 0.07% 238
2026
Q1
$24.5M Sell
116,141
-4,532
-4% -$976K 0.07% 233
2025
Q4
$24.8M Sell
120,673
-1,373
-1% -$258K 0.07% 232
2025
Q3
$19.2M Sell
122,046
-4,219
-3% -$652K 0.05% 273
2025
Q2
$21.2M Sell
126,265
-616
-0.5% -$91.4K 0.06% 256
2025
Q1
$17.5M Sell
126,881
-308
-0.2% -$39.3K 0.06% 283
2024
Q4
$15M Sell
127,189
-3,747
-3% -$437K 0.05% 321
2024
Q3
$14.5M Sell
130,936
-2,234
-2% -$234K 0.04% 335
2024
Q2
$13.1M Sell
133,170
-1,732
-1% -$176K 0.04% 337
2024
Q1
$15.1M Sell
134,902
-2,878
-2% -$311K 0.05% 313
2023
Q4
$13.9M Sell
137,780
-5,431
-4% -$539K 0.05% 318
2023
Q3
$12.4M Sell
143,211
-3,354
-2% -$303K 0.05% 314
2023
Q2
$13.9M Sell
146,565
-3,292
-2% -$278K 0.05% 318
2023
Q1
$11.3M Sell
149,857
-912
-0.6% -$68.8K 0.04% 346
2022
Q4
$11.6M Sell
150,769
-15,578
-9% -$1.18M 0.05% 342
2022
Q3
$11.1M Buy
166,347
+1,827
+1% +$116K 0.05% 349
2022
Q2
$8.6M Sell
164,520
-2,057
-1% -$117K 0.04% 402
2022
Q1
$9.45M Sell
166,577
-2,417
-1% -$129K 0.03% 424
2021
Q4
$8.7M Sell
168,994
-9,154
-5% -$449K 0.03% 452
2021
Q3
$8.81M Sell
178,148
-6,738
-4% -$366K 0.03% 431
2021
Q2
$10.6M Sell
184,886
-12,209
-6% -$713K 0.04% 417
2021
Q1
$12M Sell
197,095
-14,124
-7% -$780K 0.04% 381
2020
Q4
$11.3M Sell
211,219
-5,631
-3% -$292K 0.04% 379
2020
Q3
$10.2M Sell
216,850
-18,159
-8% -$932K 0.04% 366
2020
Q2
$12.3M Sell
235,009
-13,623
-5% -$702K 0.05% 327
2020
Q1
$11.9M Buy
248,632
+4,225
+2% +$219K 0.06% 300
2019
Q4
$12.4M Sell
244,407
-4,556
-2% -$235K 0.05% 361
2019
Q3
$11.7M Buy
248,963
+152
+0.1% +$6.94K 0.05% 362
2019
Q2
$11.7M Buy
248,811
+291
+0.1% +$13.4K 0.05% 365
2019
Q1
$12.1M Buy
248,520
+3,382
+1% +$169K 0.05% 360
2018
Q4
$10.9M Sell
245,138
-8,351
-3% -$435K 0.05% 342
2018
Q3
$13.7M Sell
253,489
-7,833
-3% -$401K 0.06% 330
2018
Q2
$12.8M Sell
261,322
-4,616
-2% -$262K 0.06% 349
2018
Q1
$16.7M Sell
265,938
-6,598
-2% -$453K 0.07% 284
2017
Q4
$16.7M Sell
272,536
-3,609
-1% -$223K 0.07% 292
2017
Q3
$18.5M Buy
276,145
+1,977
+0.7% +$140K 0.08% 267
2017
Q2
$21.4M Buy
274,168
+117
+0% +$8.83K 0.1% 236
2017
Q1
$22.3M Buy
274,051
+4,174
+2% +$329K 0.11% 221
2016
Q4
$19.4M Buy
269,877
+2,172
+0.8% +$157K 0.1% 225
2016
Q3
$20.8M Sell
267,705
-12,478
-4% -$1.01M 0.11% 215
2016
Q2
$21.9M Buy
280,183
+446
+0.2% +$35.6K 0.12% 200
2016
Q1
$22.9M Buy
279,737
+6,697
+2% +$545K 0.13% 181
2015
Q4
$24.4M Buy
273,040
+3,640
+1% +$309K 0.14% 163
2015
Q3
$20.7M Buy
269,400
+7,737
+3% +$647K 0.13% 186
2015
Q2
$21.9M Buy
261,663
+3,904
+2% +$345K 0.13% 190
2015
Q1
$23.3M Buy
257,759
+8,389
+3% +$722K 0.14% 182
2014
Q4
$20.1M Sell
249,370
-8,681
-3% -$686K 0.13% 190
2014
Q3
$19.3M Buy
258,051
+13,163
+5% +$958K 0.13% 195
2014
Q2
$16.8M Sell
244,888
-6,955
-3% -$474K 0.12% 201
2014
Q1
$17.6M Buy
251,843
+2,146
+0.9% +$149K 0.13% 195
2013
Q4
$16.7M Buy
249,697
+4,357
+2% +$266K 0.12% 194
2013
Q3
$12.8M Buy
245,340
+4,147
+2% +$211K 0.1% 223
2013
Q2
$11.4M Buy
+241,193
New +$11M 0.1% 237

Other funds holding CAH

Chevy Chase Trust's CAH Position: Q2 2026 in Review

Chevy Chase Trust reduced its Cardinal Health (CAH) stake by 2.5% in Q2 2026, selling an estimated $591K and leaving 113,295 shares worth $26.9M. The position accounts for 0.07% of the portfolio, ranked #238.

Chevy Chase Trust first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Chevy Chase Trust held 113,295 shares of Cardinal Health worth $26.9M as of Q2 2026.
  • Chevy Chase Trust sold 2,846 Cardinal Health shares in Q2 2026, an estimated $591K.
  • Cardinal Health made up 0.07% of Chevy Chase Trust's portfolio in Q2 2026, its #238 holding.
  • Chevy Chase Trust first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.